CClinicalTrials.gg
CompletedNCT03211689Updated Sep 6, 2018

The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease

An interventional study of Exercise Program in Primary Immune Deficiency Disorder, Common Variable Immunodeficiency and Specific Antibody Deficiency, sponsored by Stockton University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-09-06.

Sponsored by Stockton University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This aim of this research project is to determine if low to moderate level exercise can have an impact on stress, fatigue, and quality of life for individuals diagnosed with a primary immunodeficiency disease. This 8-week study will compare participants engaging in a semi-customized, home exercise program (exercise intervention group) to participants performing normal activities (non-exercise control group). This study will track stress, fatigue, and quality of life in individuals with a diagnosis of primary immunodeficiency disease, using standardized questionnaires, journals, and interviews.

Read the detailed description

This aim of this research project is to determine if low to moderate level exercise can have an impact on stress, fatigue, and quality of life for individuals diagnosed with a primary immunodeficiency disease. Many individuals diagnosed with primary immunodeficiency disease report chronic fatigue and/or pain, which can potentially limit their participation in exercise and physical activities. Research shows that regular exercise can improve both physical and mental health for individuals diagnosed with a chronic medical condition. Exercise is a healthy and low-cost alternative to some medications, and may be an effective addition to the treatment plan for many patients with primary immunodeficiency disease. Research also suggests that low level exercise may be beneficial to immune function, while intense, or prolonged exercise can be harmful. This 8-week study will compare participants engaging in a semi-customized, home exercise program (exercise intervention group) to participants performing normal activities (non-exercise control group). This study will track stress, fatigue, and quality of life, using standardized questionnaires, journals, and interviews. Weekly contact will be made with all participants throughout the 8 weeks of the study. Individuals in the exercise group will be asked to complete up to 150 minutes of exercise, per week, at the 11-14 rating of perceived exertion. Participants who are randomized to the control group will continue their normal activities; they will also be given the opportunity to participate in the exercise program at the end of the 8 week study. To help assess the safety of a low to moderate level exercise program for individuals with primary immunodeficiency disease, this research will track the number of infections, non-planned medical visits, or increased medication usage during the study (compared to 8 weeks prior to the intervention). This research will help provide valuable information about the safety and effectiveness of an exercise program for individuals with a primary immunodeficiency disease.

02

Conditions studied

  • Primary Immune Deficiency Disorder
  • Common Variable Immunodeficiency
  • Specific Antibody Deficiency
  • Hypergammaglobulinemia

Keywords

  • Exercise
  • Stress
  • Fatigue
  • Quality of Life
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years of age or older.
  • Physician diagnosis of a primary immunodeficiency disease (as evidenced by physician letter or medical documentation/report)
  • Willingness to participate in eight-week exercise program

Exclusion criteria

Exclusion Criteria:

  • Current participation in a structured exercise program for greater than 75 minutes per week
  • Any medical condition that prevents participation in a low to moderate level exercise program (such as, but not limited to, uncontrolled asthma, unstable cardiac condition, acute orthopedic injury which requires restricted activities)
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Exercise Group

    Participants will engage in up to 150 minutes of exercise per week, at a level of 11-14 on the Borg Rate of Perceived Exertion scale.

    Other: Exercise Program

  • No intervention
    Control Group

    Participants will continue normal activities, with no new participation in exercise program (may engage in less than 75 minutes of non-structured exercise per week).

Interventions

  • OtherExercise Program

    Participants will utilize the Physitrack exercise program to engage in up to 150 minutes of exercise at a rating of 11-14 on the Borg Rate of Perceived Exertion scale, per week.

05

What researchers measure

Primary outcomes

  1. Short Form 36 version 2

    Measure of quality of life.

    Time frame: Change during 8 weeks

Secondary outcomes

  1. Infection Incidence

    Measure of number of infections that have occurred

    Time frame: Change from 8 weeks prior to the start of study to the 8 weeks during the study

  2. Unplanned use of medical provider

    Number of unplanned visits to a medical provider

    Time frame: Change from 8 weeks prior to the start of the study to the 8 weeks during the study.

  3. Fatigue Impact Scale

    Measure of fatigue.

    Time frame: Change during 8 weeks

  4. Exercise Benefits/Barriers Scale

    Measure of perceptions about exercise.

    Time frame: Change during 8 weeks

  5. Perceived Stress Scale 10

    Measure of stress.

    Time frame: Change during 8 weeks

  6. Self-efficacy for Exercise Scale

    Measure about ability to comply with exercise program

    Time frame: Change during 8 weeks

  7. Subjective Exercise Experience Scale

    Measures perceptions about participation in an exercise program

    Time frame: Change during 8 weeks

06

Study locations

1 site
  • Stockton University
    Galloway, New Jersey 08205, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03211689
Lead sponsor
Stockton University
Collaborators
Nova Southeastern University
Responsible party
Kerri Sowers PT, DPT, NCS (Assistant Professor of Health Science, Stockton University) — Principal investigator
First posted
Jul 7, 2017
Start date
Jun 27, 2017
Primary completion
Dec 31, 2017
Completion
Dec 31, 2017
Last update
Sep 6, 2018

Study contacts

Kerri Sowers, PT, DPT, NCS
principal investigator · Stockton University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion